DH introduces Bill for new drug pricing controls
The Department of Health has introduced a new Bill in parliament that will enable the government to limit the cost of unbranded medicines in case of unreasonable price increases.
Read More
Tag: Health Service Medical Supplies (Costs) Bill
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
